Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
28.26
+0.78 (2.84%)
May 4, 2026, 4:00 PM EDT - Market closed
Revenue by Segment
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 1.20M | 686.00K | 883.00K | 912.00K | 960.00K | |
Biotechnology (Startups) Growth | 74.78% | -22.31% | -3.18% | -5.00% | -3.32% | |
| 1.20M | 686.00K | 883.00K | 912.00K | 960.00K | |
| 74.78% | -22.31% | -3.18% | -5.00% | -3.32% | |
Source: S&P Global Market Intelligence.